Vericel Corp — Investor Presentation 2015

Jan 12, 2015

8-K 1 a15-2165_18k.htm 8-K

*UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549*

*FORM 8-K*

*CURRENT REPORT*

*Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934*

Date of Report (Date of Earliest Event Reported): January 12, 2015

*Vericel Corporation* (Exact name of registrant as specified in its charter)

Michigan	001-35280	94-3096597
(State or other jurisdiction	(Commission	(I.R.S. Employer
of incorporation)	File Number)	Identification No.)
64 Sidney St. Cambridge, Massachusetts		02139
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (734) 418-4400

*Not Applicable* Former name or former address, if changed since last report

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

SEQ.=1,FOLIO='',FILE='C:\JMS\108687\15-2165-1\task7141244\2165-1-ba.htm',USER='108687',CD='Jan 12 04:09 2015'

*Item 7.01. Regulation FD Disclosure.*

On January 12, 2015, Vericel Corporation (the “Company”) prepared an updated company presentation. A copy of the presentation is furnished herewith as Exhibit 99.1.

The information in Item 7.01 of this Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

*Item 9.01. Financial Statements and Exhibits.*

(d) Exhibits.

Exhibit No.	Description
99.1	Investor presentation dated January 12, 2015.

2

SEQ.=1,FOLIO='2',FILE='C:\JMS\108687\15-2165-1\task7141244\2165-1-ba.htm',USER='108687',CD='Jan 12 04:09 2015'

*SIGNATURES*

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Vericel Corporation
Date: January 12, 2015	By:
	/s/ Dominick C. Colangelo
	Name: Dominick C. Colangelo
	Title: President and Chief Executive Officer

3

SEQ.=1,FOLIO='3',FILE='C:\JMS\108687\15-2165-1\task7141244\2165-1-ba.htm',USER='108687',CD='Jan 12 04:09 2015'

Exhibit Index

Exhibit No.	Description
99.1	Investor presentation dated January 12, 2015.

4

SEQ.=1,FOLIO='4',FILE='C:\JMS\108687\15-2165-1\task7141244\2165-1-ba.htm',USER='108687',CD='Jan 12 04:09 2015'